A race against time and against ourselves. Against the dangerous idea that we can’t do this, that there is no way.
Unlike most races, it won’t have one winner. In this race we all win, or we all lose. Winning it requires a radical, unprecedented level of collaboration, from all corners of our world. From our cities, businesses, regions and investors. From people everywhere.
Together we’re racing for a better world. A zero carbon and resilient world. A healthier, safer, fairer world. A world of wellbeing, abundance and joy, where the air is fresher, our jobs are well-paid and dignified, and our future is clear.
To get there we need to run fast, and get faster. We need more and more people to join the race, and right now. This is not about 2050, it’s about today.
Together, we can do this. And we’re already on our way.
Pharma & med tech announce critical climate breakthrough
By Climate Champions | September 22, 2021
The pharmaceutical and medical technology sector is the latest to join a group of 15 major industries that have achieved a major breakthrough in climate action.
To reach this milestone means that over 20% of major actors by revenue within the sector have joined the Race to Zero campaign — the world’s largest alliance of non-state actors credibly committed to halving emissions, at the very latest, by 2030.
The Climate Champions congratulates these businesses, as well as Accelerators such as the Sustainable Healthcare Coalition, for their commitments and contributions to building a low-carbon, resilient, and healthier world. Looking to COP26 and beyond, we encourage more sector actors to join them on this fundamental journey.
Role of sector in mitigating emissions
Pharma and med tech companies are pivotal in decarbonizing healthcare, especially given the nature of healthcare’s interlinks between public and private partnerships, which are critical to catalyzing climate action.
“With a growing impact of climate change on health, the Healthcare sector also needs to take responsibility in driving a sustainable net-zero transformation. Close partnerships between government and the private sector, as well as cross sector collaboration will be essential in the fight against climate change,” said Susanne Andreae, Head of Health and Healthcare Industry, World Economic Forum.
Many companies are already firmly on a net zero trajectory. Philips’ initiatives, for example, include sourcing over 75% of its total energy consumption from renewable sources by 2025. Its operations, as of last year, are already carbon-neutral. Similarly, GSK has committed to net zero emissions across its full biopharma value chain by 2030.
Innovation and technological advances will be critical in driving down sector emissions. Biogen’s Green Chemistry programme, for instance, aims to innovate processes to improve product performance whilst delivering environmental benefits. Its “green-by-design” approach to two early phase pipeline projects, aiming to treat multiple sclerosis and neuropathic pain, could result in up to 70% waste reduction.
Johnson & Johnson (J&J), meanwhile, through their Healthy Lives Mission, has committed $800 million up to 2030 to improve the health of people and the planet through sustainable processes and product innovation. Increasing investments in technology will drive innovation within the sector, delivering both economic and environmental gains.
Breakthrough Outcome
Beyond reaching Breakthrough Ambition, the UNFCCC 2030 Breakthroughs Campaign also includes sector-specific Breakthrough Outcomes for 2030.
Given the high emissions attributed to Research and Development (R&D) via laboratories and procurement, the sectors’ Breakthrough Outcome is for “95% of labs across major pharma and med tech companies” to be “My Green Lab certified at the green level by 2030”. The Green Lab Certification, run by My Green Lab, is the “global standard for laboratory sustainability best practices” and acts as a catalyst for achieving sustainability in science. AstraZeneca has already adopted this Certification in over 65 labs worldwide, helping them to decarbonize healthcare R&D.
To achieve this Breakthrough Outcome, all key pharma and med tech businesses must play their part by setting ambitious sustainability goals. Together, the sector can work to deliver these commitments and ultimately achieve net zero.
With 40 days to go before the pivotal COP26 climate conference in Glasgow this November, over half the sectors that make up the global economy are now committing to halve their emissions within the next decade and achieve near-term emissions reductions targets known as the 2030 Breakthroughs.
The road to a fully decarbonized electricity system is clear. We must rapidly phase out fossil fuels whilst simultaneously accelerating our expansion of renewables. The transition to clean power is the crucial foundation of the energy transition, and achievement of the Race to Zero breakthrough ambition is a key step forward in achieving our sector goal of net zero.
To help catalyse action, the UN High Level Climate Champions have updated an existing Breakthroughs paper to include additional specificity on halving emissions by 2030 across more sectors of the real economy.
Our parent’s generation put a man on the moon eight years after JFK’s commitment to do so in May 1961. In this decisive decade, when faced with the threat of a climate emergency, how can we do any less? In corporate boardrooms across the world, the challenge is increasingly being accepted: climate change poses an […]